Effects of Baricitinib, Empagliflozin, Linagliptin and Telmisartan on Cardiovascular Autonomic Neuropathy in Type 1 Diabetes: an Exploratory, Randomized, Open‐label, Crossover Trial
DIABETES OBESITY & METABOLISM(2023)
关键词
clinical trial,diabetes complications,diabetic neuropathy,empagliflozin,linagliptin,SGLT2 inhibitor
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要